PTGR1
Basic information
Region (hg38): 9:111549722-111599893
Previous symbols: [ "LTB4DH" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (38 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTGR1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001146108.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 35 | 39 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 35 | 4 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PTGR1 | protein_coding | protein_coding | ENST00000407693 | 9 | 50134 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 3.54e-8 | 0.341 | 125517 | 0 | 231 | 125748 | 0.000919 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.412 | 164 | 180 | 0.914 | 0.00000913 | 2123 |
| Missense in Polyphen | 41 | 46.604 | 0.87975 | 560 | ||
| Synonymous | 0.364 | 62 | 65.8 | 0.943 | 0.00000351 | 650 |
| Loss of Function | 0.669 | 13 | 15.9 | 0.819 | 6.66e-7 | 220 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000541 | 0.000539 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00171 | 0.00171 |
| European (Non-Finnish) | 0.00133 | 0.00132 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.000882 | 0.000882 |
| Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4. {ECO:0000250}.;
- Pathway
- Nuclear Receptors Meta-Pathway;NRF2 pathway;Metabolism of lipids;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Glycine Serine metabolism;Synthesis of Lipoxins (LX);Metabolism;Biosynthesis of specialized proresolving mediators (SPMs);Fatty acid metabolism;sphingosine and sphingosine-1-phosphate metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0989
Intolerance Scores
- loftool
- 0.955
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 61.73
Haploinsufficiency Scores
- pHI
- 0.0900
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0766
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptgr1
- Phenotype
Gene ontology
- Biological process
- leukotriene metabolic process;prostaglandin metabolic process;oxidation-reduction process;response to antineoplastic agent
- Cellular component
- cytoplasm;extracellular exosome
- Molecular function
- 2-alkenal reductase [NAD(P)] activity;13-prostaglandin reductase activity;15-oxoprostaglandin 13-oxidase activity